/ /


Latest tonometry devices all have their pluses and minusesYvonne Buys, MD, says ophthalmologists can choose from a range of the latest devices for measuring IOP, each with its own strengths and weaknesses. While new technology continues to emerge, Dr. Buys provides an overview of tonometer technology.
Aflibercept shows macular perfusion gains in VISTA subanalysisThe use of aflibercept led to greater improvement in macular perfusion status in a phase III trial with DME patients. Those with baseline nonperfusion tended to have more advanced disease.
Respect patients' trust during eyewear selection
Respect patients' trust during eyewear selectionBuild a rapport with patients and understand they are placing trust in staffers when choosing new glasses. Tami Hagemeyer, ABOC, FNAO, offers suggestions to maximize patients' satisfaction with the process.
AMD trial data are highlights at recent conferencesClinical trial data focusing on treatment for age-related macular degeneration (AMD) have been a highlight at many recent ophthalmology meetings. Here are a few of the latest clinical trials that physicians need to be aware.
Patient-assistance programs for AMD treatmentsAlthough a proven treatment therapy, age-related macular degeneration (AMD) requires frequent, costly anti-vascular endothelial growth factor (anti-VEGF) injections. Some pharmaceutical companies do have patient-assistance programs to help alleviate the financial burden.
APL-2 slows growth of GA in phase II safety and efficacy trialTwelve-month results of the FILLY trial show that in patients with geographic atrophy, the administration of complement C3 inhibitor APL-2 slowed the growth rate of the disease. It also appeared to increase the risk of new onset AMD, although this did not have an adverse effect on visual outcomes.
Sequenced approach offers effective retinectomy with less complicationsA retinectomy performed under air using a sequenced approach can improve outcomes.
ASCRS congregates under the cherry blossoms for 2018 event
ASCRS congregates under the cherry blossoms for 2018 eventSymposia, instructional courses, skills transfer labs, films, poster presentations will be offered during annual conference.
Identifying and responding to child and elder abuse
Identifying and responding to child and elder abuseIn both child and elder abuse, timely intervention can save a life. All members of the eyecare community must be aware of the signs and symptoms of abuse and their responsibilities in reporting to appropriate authorities.
Resolve patient confusion with AMD awareness, understandingAge-related macular degeneration (AMD) is the leading cause of significant visual acuity loss in people over the age of 50 in developed countries. Almost 80% of the people diagnosed with AMD will have the non-neovascular (dry) or atrophic subtypes. Here is the clinical information patients need to understand this disease.